Spots Global Cancer Trial Database for pneumonitis
Every month we try and update this database with for pneumonitis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD | NCT06192004 | Non-Small Cell ... | None (Observati... | 18 Years - | AstraZeneca | |
| Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) | NCT04721444 | Lung Cancer Covid19 Pneumonitis | Machine Learnin... Machine Learnin... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis | NCT04036721 | Lung Neoplasm M... Interstitial Lu... | Prolonged gluco... Short glucocort... | 18 Years - | National Institute for Tuberculosis and Lung Diseases, Poland | |
| Prediction of Everolimus-induced Interstitial Lung Disease | NCT01978171 | Breast Neoplasm... | 18 Years - | Radboud University Medical Center | ||
| Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies | NCT02788643 | Chronic Obstruc... Infectious Pneu... Pneumonitis Lung Cancer | biological flui... | 18 Years - | CHU de Reims | |
| Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP | NCT05280873 | Pneumonitis Malignant Tumor | Pirfenidone, me... Methylprednisol... | 18 Years - 75 Years | Guangzhou Institute of Respiratory Disease | |
| Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD | NCT06192004 | Non-Small Cell ... | None (Observati... | 18 Years - | AstraZeneca | |
| Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD | NCT06192004 | Non-Small Cell ... | None (Observati... | 18 Years - | AstraZeneca | |
| Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | NCT00081315 | Esophagitis Pneumonitis Non-Small Cell ... | Amifostine | 18 Years - | MedImmune LLC | |
| Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies | NCT02788643 | Chronic Obstruc... Infectious Pneu... Pneumonitis Lung Cancer | biological flui... | 18 Years - | CHU de Reims | |
| Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis | NCT04040244 | Pneumonitis Nonsmall Cell L... | Exhaled Breath ... Blood sample | 18 Years - | Wake Forest University Health Sciences | |
| Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis | NCT04040244 | Pneumonitis Nonsmall Cell L... | Exhaled Breath ... Blood sample | 18 Years - | Wake Forest University Health Sciences | |
| The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors | NCT05219851 | Cancer Patients | Cancer patients... | - | Hubei Cancer Hospital | |
| Tocilizumab for Patients With Cancer and COVID-19 Disease | NCT04370834 | Hematopoietic a... Malignant Solid... Pneumonia Pneumonitis Severe Acute Re... Symptomatic COV... | Tocilizumab | 2 Years - | National Cancer Institute (NCI) | |
| Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD | NCT06192004 | Non-Small Cell ... | None (Observati... | 18 Years - | AstraZeneca | |
| Everolimus Related Pneumonitis in MBC | NCT03730428 | Everolimus Pneumonitis | 18 Years - | Fudan University | ||
| Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. | NCT04381494 | Unresectable St... | Multiparametric... | 18 Years - 130 Years | AstraZeneca | |
| Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) | NCT04721444 | Lung Cancer Covid19 Pneumonitis | Machine Learnin... Machine Learnin... | 18 Years - | Royal Marsden NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
